CV Therapeutics
Jun 23, 2008
Wait a Little Longer, Ligand
On Friday, the duo announced that the FDA delayed the review of their blood-disorder drug Promacta by as much as three months.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Great site for CV, Resumes, Cover Letter Help, ... | Apr '08 | Milton | 1 |
Cancer
Most Popular